Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.25B
Enterprise Value7.73B
P/E Ratio21.58
PEG Ratio-1.02
Price/Sales Ratio4.19
Price/Book Ratio2.68
Enterprise/Revenue3.83
Enterprise/EBITDA12.39

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.21
Operating Margin0.27
AD

Management Effectiveness

Return On Assets0.1
Return On Equity0.13

Income Statement

Revenue2.05B
Revenue/Share3.45
Gross Profit1.56B
EBITDA675.98M
Net Income433.13M
Diluted EPS0.74

Balance Sheet

Total Cash1.58B
Total Cash/Share2.68
Total Debt267.9M
Total Debt/Equity0.08
Current Ratio4.69
Book Value Per Share5.73

Price History

52-Week Change-1.22
52-Week High19.32
52-Week Low11.82
Moving Average 50 Days13
Moving Average 200 Days13.49

Statistics

Average Volume8.9M
Shares Outstanding553.69M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.45
Trailing Annual Dividend Yield2.93
Payout Ratio0.72
Last Split Factor13:10
Last Split DateApril 21, 2011
AD